Kronox Lab Sciences Reports Q2 FY27 Financial Results
Kronox Lab Sciences Ltd · Financial Result · 05 Nov 2026, 7:47 pm
Kronox Lab Sciences Reports Q2 FY27 Financial Results Kronox Lab Sciences reported revenue from operations of ₹2,683.42 lakhs for the quarter ended 30th Sep'26, up 5.10% YoY from ₹2,553.32 lakhs, but down 5.47% QoQ. Profit After Tax stood at ₹644.03 lakhs compared to ₹667.63 lakhs in the year-ago period and ₹730.30 lakhs in Q1. EPS for the quarter was ₹1.73. Indo Borax & Chemicals acquired a 64.26% controlling stake on 29th Sep'26, becoming the holding company with subsequent board and management changes. Total borrowings were completely repaid as of 30th Sep'26.
Original exchange filing (PDF)
More announcements from Kronox Lab Sciences Ltd
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... · 11 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 10, 2026 for Indo Borax .... · 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd · 06 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2026 for Indo Borax & Chemicals Ltd · 06 Nov 2026
- IIFL Capital Services Ltd (formerly known as IIFL Securities Ltd) ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Public Announcement in accordance with Regulation .... · 05 Nov 2026
- Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Outcome of Board Meeting held on Thursday, November 05, 2026 inter to consider and approve unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026 · 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 05 Nov 2026
